Distinguishing reference intervals and clinical decision limits – A review by the IFCC Committee on Reference Intervals and Decision Limits

References

• Ceriotti F, Henny J. Are my laboratory results normal? Considerations to be made concerning reference intervals and decision limits. EJIFCC. 2008;19:1–9.
   Google Scholar
• CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. 3rd ed. CLSI EP28-A3c. Wayne, Pennsylvania: Clinical and Laboratory Standards Institute; 2010.
   Google Scholar
• Keyser JW. The concept of the normal range in clinical chemistry. Postgrad Med J. 1965;41:443–447.
   PubMed Web of Science ®Google Scholar
• Sunderman FW. Current concepts of “normal values,” “reference values,” and “discrimination values,” in clinical chemistry. Clin Chem. 1975;21:1873–1877.
   PubMed Web of Science ®Google Scholar
• Murphy EA, Abbey H. The normal range-a common misuse. J Chronic Dis. 1967;20:79–88.
   PubMedGoogle Scholar
• International Organization for Standardization. Medical laboratories – Requirements for quality and competence. ISO 15189:2012. [cited 2018 Jun 9]. Available from: https://doi.org/https://www.iso.org/standard/56115.html https://www.iso.org/standard/56115.html
   Google Scholar
• Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1986) on the theory of reference values. Part 1. The concepts of reference values. J Clin Chem Clin Biochem. 1987;25:337–342.
   PubMedGoogle Scholar
• Petit Clerc C, Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individual for the production of reference value. J Clin Chem Clin Biochem. 1987;25:337–342.
   PubMedGoogle Scholar
• Solberg HE, Petit, Clerc C. International Federation of Clinical Chemistry (IFCC). Approved recommendation on the theory of reference values. Part 3. Preparation of individuals and collection of the specimens for the production of reference values. J Clin Chem Clin Biochem. 1988;26:593–598.
   PubMedGoogle Scholar
• Solberg HE, Stamm D. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1991) on the theory of reference values. Part 4. Control of analytical variation in the production, transfer and application of reference values. J Clin Chem Clin Biochem. 1991;29:531–535.
   Google Scholar
• Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation on the theory of reference values. Part 5. Statistical treatment of collected reference values. Clin Chem Clin Biochem. 1987;25:645–656.
   Google Scholar
• Dybkaer R, Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 6. Presentation of observed values related to reference values. J Clin Chem Clin Biochem. 1987;25:657–662.
   Google Scholar
• Ozarda Y, Ichihara K, Barth JH, et al. Committee on Reference Intervals and Decision Limits (C-RIDL), IFCC. Protocol and standard operating procedures for common use in worldwide multicenter study on reference values. Clin Chem Lab Med. 2013;51:1027–1040.
   PubMed Web of Science ®Google Scholar
• Ichihara K, Ozarda Y, Barth JH, et al. Committee on Reference Intervals and Decision Limits (C-RIDL), IFCC. A global multicentre study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals. Clin Chim Acta. 2017;467:70–82.
   PubMed Web of Science ®Google Scholar
• Ichihara K, Ozarda Y, Barth JH, et al. Committee on Reference Intervals and Decision Limits (C-RIDL), IFCC. A global multicentre study on reference values: 2. Exploration of sources of variation across the countries. Clin Chim Acta. 2017;467:83–97.
   PubMed Web of Science ®Google Scholar
• Baadenhuijsen H, Smit JC. Indirect estimation of clinical chemical reference Intervals from total hospital patient data: application of a modified Bhattacharya procedure. J Clin Chem Clin Biochem. 1985;23:829–839.
   PubMedGoogle Scholar
• Directive 98/79/EC to the European Parliaments and of the Council 1998-10-27 on in vitro Diagnostic Medical Devices. 1998 OJ (L 331), 1. [cited 2018 Jun 15]. Available from: https://doi.org/https://ec.europa.eu/growth/single-market/european-standards/harmonised-standards/iv-diagnostic-medical-devices_en
   Google Scholar
• Jones GR. Validating common reference intervals in routine laboratories. Clin Chim Acta. 2014;432:119–121.
   PubMed Web of Science ®Google Scholar
• Sikaris K. Physiology and its importance for reference intervals. Clin Biochem Rev. 2014;35:3–14.
   PubMedGoogle Scholar
• EMA: Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus. European Medicines Agency; 2012 [cited 2018 June 15]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129-256.pdf
   Google Scholar
• Expert Committee on the Diagnosis Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5–S20.
   PubMed Web of Science ®Google Scholar
• Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561–577.
   PubMed Web of Science ®Google Scholar
• Kallner A. Bayes' theorem, the ROC diagram and reference values: Definition and use in clinical diagnosis. Biochem Med (Zagreb). 2018;28:010101.
   PubMed Web of Science ®Google Scholar
• Reach G. Which threshold to detect hypoglycemia? Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity. Diabetes Care. 2001;24:803–804.
   PubMed Web of Science ®Google Scholar
• Greene DN, Tate JR. Establishing consensus-based, assay specific 99th percentile upper reference limits to facilitate proper utilization of cardiac troponin measurements. Clin Chem Lab Med. 2017;55:1675–1682.
   Web of Science ®Google Scholar
• Clerico A, Zaninotto M, Ripoli M, et al.; on the behalf of the Study Group on Cardiovascular Risk Biomarkers of the Italian Society of Clinical Biochemistry (SIBioC). The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications. Clin Chem Lab Med. 2017;55:1634–1651.
   Google Scholar
• Bast RC Jr, Klug TL, St John E, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983;309:883–887.
   PubMed Web of Science ®Google Scholar
• Vuento MH, Stenman UH, Pirhonen JP, et al. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer. Gynecol Oncol. 1997;64:141–146.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007–2011.
   PubMed Web of Science ®Google Scholar
• Olson F, Engborg J, Grønhøj MH, et al. Association between high-sensitive troponin I and coronary artery calcification in a Danish general population. Atherosclerosis. 2016;245:88–93.
   PubMed Web of Science ®Google Scholar
• Loeb S, Roehl KA, Antenor JA, et al. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old. Urology. 2006;67:316–320.
   PubMed Web of Science ®Google Scholar
• Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem. 1990;36:265–270.
   PubMed Web of Science ®Google Scholar
• Sikaris K, McLachlan RI, Kazlauskas R, et al. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab. 2005;90:5928–5936.
   PubMed Web of Science ®Google Scholar
• Krintus M, Kozinski M, Boudry P, et al. Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I. Int J Cardiol. 2015;187:256–263.
   PubMed Web of Science ®Google Scholar
• Haeckel R, Wosniok W, Arzideh F, et al. Critical comments to a recent EFLM recommendation for the review of reference intervals. Clin Chem Lab Med. 2017;55:341–347.
   PubMed Web of Science ®Google Scholar
• Zierk J, Arzideh F, Haeckel R, et al. Pediatric reference intervals for alkaline phosphatase. Clin Chem Lab Med. 2017;55:102–110.
   PubMed Web of Science ®Google Scholar
• Grecu DS, Paulescu E. Quality in post-analytical phase: Indirect reference intervals for erythrocyte parameters of neonates. Clin Biochem. 2013;46:617–621.
   PubMed Web of Science ®Google Scholar
• Kouri T, Kairisto V, Virtanen A, et al. Reference intervals developed from data for hospitalized patients: Computerized method based on combination of laboratory and diagnostic data. Clin Chem. 1994;40:2209–2215.
   PubMed Web of Science ®Google Scholar
• Bhattacharya CG. A simple method of resolution of a distribution into Gaussian components. Biometrics. 1967;23:115–135.
   PubMed Web of Science ®Google Scholar
• Jones G, Horowitz G. Reference intervals Data mining: getting the right paper. Am J Clin Pathol. 2015;144:526–527.
   Web of Science ®Google Scholar
• Jones G, Haeckel R, Loh TP, et al. Indirect methods for reference interval determination – review and recommendations. Clin Chem Lab Med. 2018. DOI: 10.1515/cclm-2018-0073
   Web of Science ®Google Scholar
• Ceriotti F. Prerequisites for use of common reference intervals. Clin Biochem Rev. 2007;28:115–121.
   PubMedGoogle Scholar
• Colantonio DA, Kyriakopoulou L, Chan MK, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem. 2012;58:854–868.
   PubMed Web of Science ®Google Scholar
• Adeli K, Raizman JE, Chen Y, et al. Complex biological profile of hematologic markers across pediatric, adult, and geriatric ages: Establishment of robust pediatric and adult reference intervals on the basis of the Canadian Health Measures Survey. Clin Chem. 2015;61:1075–1086.
   PubMed Web of Science ®Google Scholar
• Hilsted L, Rustad P, Aksglaede L, et al. Recommended Nordic paediatric reference intervals for 21 common biochemical properties. Scand J Clin Lab Invest. 2013;73:1. 9.
   PubMed Web of Science ®Google Scholar
• Berg J. The UK Pathology Harmony initiative; The foundation of a global model. Clin Chim Acta. 2014;432:22–26.
   PubMed Web of Science ®Google Scholar
• Tate JR, Sikaris KA, Jones GR, et al. and paediatric reference intervals in Australia and New Zealand: An evidence-based approach for establishing. A First Panel of Chemistry Analytes. Clin Biochem Rev. 2014;35:213–235.
   PubMedGoogle Scholar
• Koerbin G, Tate JR. Harmonising adult reference intervals in Australia and New Zealand – the continuing story. Clin Biochem Rev. 2016;37:121–129.
   PubMedGoogle Scholar
• Hawkins RC, Johnson RN. The significance of significant figures. Clin Chem. 1990;36:824.
   PubMed Web of Science ®Google Scholar
• Tate JR, Koerbin G, Adeli K. Opinion paper: Deriving harmonised reference intervals – global activities. EJIFCC. 2016;27:48–65.
   PubMedGoogle Scholar
• Lindstedt G, Tryding N. There is difference between decision limits and reference intervals. Reference intervals are based on measurements in healthy individuals, decision limits on measurements in patients. Lakartidningen. 2007;104:2076–2079.
   PubMedGoogle Scholar
• Waise A, Price HC. The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism. Ann Clin Biochem. 2009;46:93–98.
   PubMed Web of Science ®Google Scholar
• Abbott RD, Wilson PW, Kannel WB, et al. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 1988;8:207–211.
   PubMedGoogle Scholar
• Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive therapy of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
   PubMed Web of Science ®Google Scholar
• White GH, Campbell CA, Horvath AR. Is this a critical, panic, alarm, urgent, or markedly abnormal result? Clin Chem. 2014;60:1569–1570.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90.
   PubMed Web of Science ®Google Scholar
• Geng J, Zhang Y, Wang B, et al. Glycosylated haemoglobin levels and clinical outcomes in nondiabetic patients with coronary artery disease. Medicine. 2017;96:e6784–e6786.
   PubMed Web of Science ®Google Scholar
• Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362:800–811.
   PubMed Web of Science ®Google Scholar
• International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–682.
   PubMed Web of Science ®Google Scholar
• HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58:453–459.
   PubMed Web of Science ®Google Scholar
• Metzger BE, Gabbe SG, Persson B, et al. International Association of Diabetes & Pregnancy Study Groups (IADPSG) Consensus Panel Writing Group and the Hyperglycemia & Adverse Pregnancy Outcome (HAPO) Study Steering Committee. The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med. 2012;25:2564–2569.
   PubMed Web of Science ®Google Scholar
• International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol. 1997;15:594–603.
   PubMed Web of Science ®Google Scholar
• von Eyben FE. Laboratory markers and germ cell tumors. Crit Rev Clin Lab Sci. 2003;40:377–427.
   PubMed Web of Science ®Google Scholar
• Campbell C, Caldwell G, Coates P, et al. Consensus statement for the management and communication of high risk laboratory results. Clin Biochem Rev. 2015;36:97–105.
   PubMedGoogle Scholar
• Sikaris KA, Martin A, Guerin MD. Relationship between reference intervals and mortality-based reference ranges. Clin Biochem Rev. 1991;12:S81.
   Google Scholar
• Asadollahi K, Hastings IM, Beeching NJ, et al. Laboratory risk factors for hospital mortality in acutely admitted patients. QJM. 2007;100:501–507.
   PubMed Web of Science ®Google Scholar
• Whelan B, Bennett K, O'Riordan D, et al. Serum sodium as a risk factor for in-hospital mortality in acute unselected general medical patients. QJM 2008;102:175–182.
   PubMed Web of Science ®Google Scholar
• Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem. 2012;58:209–218.
   PubMed Web of Science ®Google Scholar
• Ricós C, Iglesias N, García-Lario JV, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem. 2007;44:343–352.
   PubMed Web of Science ®Google Scholar
• Stevens RJ, Oke J, Perera R. Statistical models for the control phase of clinical monitoring. Stat Methods Med Res. 2010;19:394–414.
   PubMed Web of Science ®Google Scholar
• Balldin J, Berggren U, Berglund K, et al. Gamma-glutamyltransferase in alcohol use disorders: Modification of decision limits in relation to treatment goals? Scand J Clin Lab Invest. 2010;70:71–74.
   PubMed Web of Science ®Google Scholar
• Levine M, O’Connor AD, Padilla-Jones A, et al. Comparison of prothrombin time and aspartate aminotransferase in predicting hepatotoxicity after acetaminophen overdose. J Med Toxicol. 2016;12:100–106.
   PubMedGoogle Scholar
• Assy N, Beniashvili Z, Djibre A, et al. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers. World J Gastroenterol. 2009;15:3025–3031.
   PubMed Web of Science ®Google Scholar
• Chang Y, Ryu S, Sung E, et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007;53:686–692.
   PubMed Web of Science ®Google Scholar
• Koerbin G, Cavanaugh JA, Potter JM, et al. 'Aussie normals': an a priori study to develop clinical chemistry reference intervals in a healthy Australian population. Pathology 2015;47:138–144.
   PubMed Web of Science ®Google Scholar
• Plebani M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med. 2006;44:750–759.
   PubMed Web of Science ®Google Scholar
• Arseneau E, Balion CM. Statistical methods used in the calculation of geriatric reference intervals: a systematic review. Clin Chem Lab Med. 2016;54:377–388.
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lunch and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Marwaha RK, Tandon N, Garg MK, et al. Normative data of body fat mass and its distribution as assessed by DXA in Indian adult population. J Clin Densitom. 2014;17:136–142.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Langsted A, Mora S, et al. European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) joint consensus initiative. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37:1944–1958.
   PubMed Web of Science ®Google Scholar
• Daly N, Turner MJ. Laboratory diagnosis of gestational diabetes mellitus. BJOG. 2016;123:1430–1433.
   PubMed Web of Science ®Google Scholar
• Devgun MS, Chan MK, El-Nujumi AM, et al. Clinical decision limits for interpretation of direct bilirubin–a CALIPER study of healthy multiethnic children and case report reviews. Clin Biochem. 2015;48:93–96.
   Web of Science ®Google Scholar
• Rodger RS, Laker MF, Fletcher K, et al. Factors influencing normal reference intervals for creatinine, urea, and electrolytes in plasma, as measured with a Beckman Astra 8 Analyzer. Clin Chem. 1985;31:292–295.
   PubMed Web of Science ®Google Scholar
• Huang M, Yang JJ, Yang JJ, et al. Reference intervals for serum creatinine levels in the healthy geriatric population. Clin Biochem. 2013;46:1419–1422.
   PubMed Web of Science ®Google Scholar
• Pottel H, Delanaye P, Weekers L, et al. Age-dependent reference intervals for estimated and measured glomerular filtration rate. Clin Kidney J. 2017;10:545–551.
   PubMed Web of Science ®Google Scholar
• Nowson CA, McGrath JJ, Ebeling PR, et al. A Position Statement. Med J Aust. 2012;199:686–687.
   Google Scholar
• Aparicio-Ugarriza R, Palacios G, Alder M, et al. A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population. Clin Chem Lab Med. 2015;53:1149–1159.
   PubMed Web of Science ®Google Scholar
• Daru J, Colman K, Stanworth SJ, et al. Serum ferritin as an indicator of iron status: what do we need to know? Am J Clin Nutr. 2017;106:1634S–1639S.
   PubMed Web of Science ®Google Scholar
• Fraser CG, Kallner A, Kenny D, et al. Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest. 1999;59:477–478.
   PubMed Web of Science ®Google Scholar
• Sikaris KA. Application of the Stockholm hierarchy to defining the quality of reference intervals and clinical decision limits. Clin Biochem Rev. 2012;33:141–148.
   PubMedGoogle Scholar
• Sandberg S, Fraser CG, Horvath AR, et al. Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015;53:833–835.
   PubMed Web of Science ®Google Scholar
• Sikaris K. Performance criteria of the post-analytical phase. Clin Chem Lab Med. 2015;53:949–958.
   PubMed Web of Science ®Google Scholar
• Petersen PH, Jensen EA, Brandslund I. Analytical performance, reference values and decision limits. A need to differentiate between reference intervals and decision limits and to define analytical quality specifications. Clin Chem Lab Med. 2011;50:819–831.
   Web of Science ®Google Scholar
• Petersen PH, Klee GG. Influence of analytical bias and imprecision on the number of false positive results using guideline-driven medical decision limits. Clin Chim Acta. 2014;430:1–8.
   PubMed Web of Science ®Google Scholar
• Ozarda Y, Higgins V, Adeli Khosrow. Verification of reference intervals in routine clinical laboratories: practical challenges and recommendation. Clin Chem Lab Med. 2018. DOI: 10.1515/cclm-2018-0059
   Google Scholar
• Bauer DT, Guerlain S, Brown PJ. The design and evaluation of a graphical display for laboratory data. J Am Med Inform Assoc. 2010;17:416–424.
   PubMed Web of Science ®Google Scholar
• Shirts BH, Larsen N, Jackson BR. Utilization and utility of clinical laboratory reports with graphical elements. J Pathol Inform. 2012;3:26.
   PubMedGoogle Scholar
• Torsvik T, Lillebo B, Mikkelsen G. Presentation of clinical laboratory results: an experimental comparison of four visualization techniques. J Am Med Inform Assoc. 2013;20:325–331.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and Laboratory implications including flagging at desirable concentration cutpoints-A joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2016;62:930–946.
   PubMed Web of Science ®Google Scholar
• Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis. 2001;156:1–10.
   PubMed Web of Science ®Google Scholar
• Bersot TP, Vega GL, Grundy SM, et al.Elevated hepatic lipase activity and low levels of high density lipoprotein in a normotriglyceridemic, nonobese Turkish population. J Lipid Res. 1999;40:432–438.
   PubMed Web of Science ®Google Scholar
• Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochem Med (Zagreb). 2016;26:5–16.
   PubMed Web of Science ®Google Scholar
• Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156–1161.
   PubMed Web of Science ®Google Scholar
• Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 1993;270:860–864.
   PubMed Web of Science ®Google Scholar
• Schroder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. N Engl J Med. 2012;366:981–990.
   PubMed Web of Science ®Google Scholar
• Andriole GL, Crawford ED, Grubb RL, et al. Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104:125–132.
   PubMed Web of Science ®Google Scholar
• Tsodikov A, Gulati R, Heijnsdijk EAM, et al. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO Trials. Ann Intern Med. 2017;167:449–455.
   PubMed Web of Science ®Google Scholar
• Vickers AJ, Cronin AM, Bjork T, et al. Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study. BMJ. 2010;341:c4521.
   PubMedGoogle Scholar